By Sabela Ojea

Novacyt SA said Thursday that it continues to work with its legal advisers to progress the U.K. Department of Health and Social Care's dispute over a supply contract.

In April the clinical-diagnostics specialist, which is listed in France and the U.K., said the parties haven't reached an agreement to extend the contract for the supply of Covid-19 diagnostic kits and other products.

The London-listed company also said that the accounting treatment of the DHSC revenue and costs in the first half doesn't change its legal position or rights in relation to the dispute.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

September 16, 2021 04:33 ET (08:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Novacyt (EU:ALNOV)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di Novacyt
Grafico Azioni Novacyt (EU:ALNOV)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di Novacyt